戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 [azaTyr(4)]-GHRP-6 (15), [Ala(1), azaPhe(2)]-GHRP-6 (16), and [azaLeu(3), Ala(6)]-GHRP-6 (33) all exh
2 ect blocked by the GHSR1 antagonist, d-Lys-3-GHRP-6.
3 g assay using a choroid explant, [azaTyr(4)]-GHRP-6 (15), [Ala(1), azaPhe(2)]-GHRP-6 (16), and [azaLe
4  For example, [A(1), azaF(4)]- and [azaY(4)]-GHRP-6 (1a and 2b) were previously shown to bind selecti
5 MK-677), growth hormone-releasing peptide 6 (GHRP-6), and the 2(R)-hydroxypropyl derivative of 3-amin
6 ogues of growth hormone releasing peptide-6 (GHRP-6) exhibit promising affinity, selectivity, and mod
7 apeptide growth hormone releasing peptide-6 (GHRP-6) exhibits dual affinity for the growth hormone se
8 Phe(2)]-GHRP-6 (16), and [azaLeu(3), Ala(6)]-GHRP-6 (33) all exhibited antiangiogenic activity.
9 trations of ghrelin on the action of MK-677, GHRP-6, and L-692,585 was analyzed globally according to
10 owed that fibrinogen-like acyl-GPRP and acyl-GHRP could inhibit D.
11                To explain acyl-GPRP and acyl-GHRP inhibition of D.E association, it is proposed that
12 acy compared with the GHSR1a peptide agonist GHRP-6, and high nanomolar to low micromolar potency, de
13 -Pro-amide (GPRP) and Gly-His-Arg-Pro-amide (GHRP), respectively.
14  sequence starts with Gly-His-Arg-Pro-amide (GHRP).
15 rnal standards (triply deuterated GHRP-4 and GHRP-2 metabolite) were used to optimize the extraction
16 iation kinetics of (125)I-[His]-ghrelin, and GHRP-6 and MK-677 were able to fully displace (125)I-[Hi
17 e polymerization inhibitor peptides GPRP and GHRP.
18 nthetic peptides GPRP (knob 'A' mimetic) and GHRP (knob 'B' mimetic).
19 eritoneal injections of the GHS-R antagonist GHRP-6 [D-Lys3] prior to subsequent transfer and sucrose
20 ced the same local conformational changes as GHRP to this site.
21 atorial split-and-mix approach furnished aza-GHRP-6 leads, which were further examined by alanine sca
22 -Trp(2), Ala(3), or Trp(4) position gave aza-GHRP-6 analogues with reduced affinity toward the GHS-R1
23                                   Azapeptide GHRP-6 analogues have been synthesized, exhibiting micro
24 abeled internal standards (triply deuterated GHRP-4 and GHRP-2 metabolite) were used to optimize the
25 all, 28 metabolites (at least three for each GHRP) were identified from the in vivo samples and main
26 s is available and merely one metabolite for GHRP-2 is established.
27 LHRH), growth hormone releasing hexapeptide (GHRP-6), and TrpCage (sequence NLYIQWLKDGGPSSGRPPPS) yie
28 hereas the ghrelin receptor antagonist D-Lys GHRP-6 reduced plasma levels of GLP-1 and insulin and di
29                                       D-Lys3-GHRP-6 and JMV 3002 also blocked ghrelin-induced increas
30 uperfusion of the GHS-R1A antagonists D-Lys3-GHRP-6 and JMV 3002 decreased evoked IPSP and mIPSC freq
31                          Furthermore, D-Lys3-GHRP-6 did not affect ethanol-induced increases in IPSP
32                        With the exemption of GHRP-2, the entity of these peptides represents nonappro
33 onferred to rEC by the peptides GPRPamide or GHRP, nor did rEC bind to a GPR peptide column.
34 cture (rfD-BbetaD432A+GH) showed the peptide GHRP was not bound to hole "b." We then re-evaluated the
35 es are the growth hormone releasing peptide (GHRP)-1, -2, -4, -5, -6, hexarelin, alexamorelin, and ip
36 ns begin with the sequence Gly-His-Arg-Pro- (GHRP-), but the homologous sequence in chicken fibrin be
37 Similarly, the lateral-association-promoting GHRP (IC30 of 1.25-1.43 mM) gave a high turbidity vs clo
38 natal rats, although to a lesser degree than GHRP-6.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。